<DOC>
	<DOCNO>NCT02137460</DOCNO>
	<brief_summary>This prospective cohort study cognitively normal ( young old ) , mild cognitive impairment , Alzheimer 's disease people</brief_summary>
	<brief_title>Korean Brain Aging Study Early Diagnosis Prediction Alzheimer 's Disease</brief_title>
	<detailed_description>The aim study 1 ) search new biomarkers develop clinically applicable early diagnosis prediction method Alzheimer 's disease , 2 ) investigate propose lifetime risk protective factor Alzheimer 's disease contribute pathological hallmark AD brain change live human annual comprehensive clinical neuropsychological evaluation biannual brain imaging ( MRI MRA , Fluorodeoxyglucose ( FDG ) -PET , Pittsburgh compound B ( PiB ) -PET ) , AV -- 1451 PET , body specimen ( blood , gene , hair ) analysis . * Note : AV-1451 PET apply whole subject , 210 subject ( 30 young CN , 60 old CN , 60 MCI , 60 AD ) .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Participants classify either Alzheimer 's disease ( AD ) group , mild cognitive impairment ( MCI ) group , elderly normal control young normal control . Specific inclusion criterion group describe . [ Inclusion criterion : AD ] Age : 55 90 Clinical Dementia Rating ( CDR ) =0.5 1 Diagnostic Statistical ManualIV ( DSMIV ) criteria dementia National Institute Aging Alzheimer 's Association ( NIAAA ) Probable AD dementia Study partner caregiver accompany patient schedule visit Written inform consent [ Inclusion criterion : MCI ( amnestic ) ] Age : 55 90 Clinical Dementia Rating ( CDR ) =0.5 Concern regard change cognition ( obtain subject , informant know subject , skilled clinician observe subject ) Lower performance episodic memory domain great would expect subject 's age educational background Preservation independence functional ability Study partner caregiver accompany subject schedule visit Written inform consent [ Inclusion criterion : Elderly normal control ] Age : 55 90 Clinical Dementia Rating ( CDR ) =0 Those contactable Informant Written inform consent [ Inclusion criterion : Young normal control ] Age : 20 55 Clinical Dementia Rating ( CDR ) =0 Written inform consent [ Exclusion criterion : general ] Past history presence major psychiatric illness ( e.g . schizophrenia , bipolar disorder , alcohol/substance abuse dependence , delirium ) Significant neurologic medical condition influence mental state Contraindications MRI scan ( e.g . pacemaker , claustrophobia ) Illiteracy Significant visual hearing difficulty Taking investigational drug In pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Early diagnosis</keyword>
	<keyword>Prediction</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Imaging</keyword>
</DOC>